Renaissance Technologies’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Buy |
2,526,734
+1,921,516
| +317% | +$17.2M | 0.03% | 651 |
|
|
2025
Q1 | $4.54M | Buy |
605,218
+60,197
| +11% | +$451K | 0.01% | 1492 |
|
|
2024
Q4 | $4.1M | Sell |
545,021
-44,059
| -7% | -$331K | 0.01% | 1576 |
|
|
2024
Q3 | $4.48M | Sell |
589,080
-371,100
| -39% | -$2.82M | 0.01% | 1517 |
|
|
2024
Q2 | $5.93M | Sell |
960,180
-630,200
| -40% | -$3.89M | 0.01% | 1199 |
|
|
2024
Q1 | $8.08M | Sell |
1,590,380
-164,600
| -9% | -$836K | 0.01% | 1113 |
|
|
2023
Q4 | $10.5M | Buy |
1,754,980
+1,553,135
| +769% | +$9.3M | 0.02% | 922 |
|
|
2023
Q3 | $1.43M | Buy |
+201,845
| New | +$1.43M | ﹤0.01% | 2065 |
|
|
2022
Q4 | – | Sell |
-565,380
| Closed | -$7.12M | – | 4115 |
|
|
2022
Q3 | $7.12M | Buy |
565,380
+438,900
| +347% | +$5.53M | 0.01% | 1217 |
|
|
2022
Q2 | $1.34M | Sell |
126,480
-125,000
| -50% | -$1.32M | ﹤0.01% | 2507 |
|
|
2022
Q1 | $4.09M | Buy |
+251,480
| New | +$4.09M | ﹤0.01% | 1739 |
|
|
2021
Q4 | – | Sell |
-408,180
| Closed | -$5.87M | – | 3894 |
|
|
2021
Q3 | $5.87M | Sell |
408,180
-624,300
| -60% | -$8.97M | 0.01% | 1361 |
|
|
2021
Q2 | $16.3M | Buy |
1,032,480
+965,010
| +1,430% | +$15.3M | 0.02% | 868 |
|
|
2021
Q1 | $686K | Sell |
67,470
-1,212,910
| -95% | -$12.3M | ﹤0.01% | 2785 |
|
|
2020
Q4 | $9.54M | Buy |
+1,280,380
| New | +$9.54M | 0.01% | 1202 |
|
|
2020
Q1 | – | Sell |
-840,734
| Closed | -$2.9M | – | 3441 |
|
|
2019
Q4 | $2.9M | Buy |
840,734
+629,919
| +299% | +$2.17M | ﹤0.01% | 2140 |
|
|
2019
Q3 | $604K | Buy |
+210,815
| New | +$604K | ﹤0.01% | 2802 |
|
|
2018
Q4 | – | Sell |
-217,203
| Closed | -$1.66M | – | 3374 |
|
|
2018
Q3 | $1.66M | Sell |
217,203
-177,378
| -45% | -$1.35M | ﹤0.01% | 2368 |
|
|
2018
Q2 | $2.26M | Sell |
394,581
-373,222
| -49% | -$2.14M | ﹤0.01% | 2204 |
|
|
2018
Q1 | $3.66M | Buy |
767,803
+371,600
| +94% | +$1.77M | ﹤0.01% | 2015 |
|
|
2017
Q4 | $1.95M | Buy |
396,203
+169,700
| +75% | +$833K | ﹤0.01% | 2364 |
|
|
2017
Q3 | $1.19M | Sell |
226,503
-178,000
| -44% | -$933K | ﹤0.01% | 2511 |
|
|
2017
Q2 | $2.25M | Buy |
404,503
+185,300
| +85% | +$1.03M | ﹤0.01% | 2201 |
|
|
2017
Q1 | $1.84M | Buy |
219,203
+169,300
| +339% | +$1.42M | ﹤0.01% | 2285 |
|
|
2016
Q4 | $316K | Buy |
+49,903
| New | +$316K | ﹤0.01% | 2895 |
|
|
2016
Q2 | – | Sell |
-292,221
| Closed | -$827K | – | 3325 |
|
|
2016
Q1 | $827K | Buy |
292,221
+149,318
| +104% | +$423K | ﹤0.01% | 2670 |
|
|
2015
Q4 | $1.48M | Buy |
+142,903
| New | +$1.48M | ﹤0.01% | 2290 |
|
|
2015
Q2 | – | Sell |
-32,403
| Closed | -$293K | – | 3221 |
|
|
2015
Q1 | $293K | Buy |
+32,403
| New | +$293K | ﹤0.01% | 2773 |
|
|
2014
Q2 | – | Sell |
-90,514
| Closed | -$958K | – | 2780 |
|
|
2014
Q1 | $958K | Buy |
+90,514
| New | +$958K | ﹤0.01% | 2103 |
|